Prognostic Impact of Moderate Secondary Mitral Regurgitation After Optimized Medical Therapy in Heart Failure.
Moderate valve leakage after optimal heart-failure treatment remains linked to prognosis, helping clinicians identify patients needing closer monitoring.
BACKGROUND: The prognostic significance of moderate secondary mitral regurgitation (MR) after optimized guideline-directed medical therapy (GDMT) in heart failure (HF) remains uncertain. METHODS: We analyzed 2,468 ambulatory HF patients with paired transthoracic echocardiography at baseline and after 12 months of optimized GDMT.
What the study was
- Study design
- Prospective paired observational study
- Category
- Diagnostics
- Maturity
- Validated
- Journal
- ESC heart failure
Why it surfaced
High triage score (8/10) based on study design (Prospective paired observational study) and direct clinical relevance; matched topic: Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic risk; flag: ⬜ Standard addition
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.